Cachexia Clinical Trial
Official title:
Development of a Screening Tool to Detect and Stage Cachectic Cancer Patients
The aim of the study is to develop a screenings tool that will enable hospital nurses to detect and stage cancer cachectic patients. The early detection and staging of cancer cachexia will assist the oncology team in providing the cachectic cancer patient tailor-made patient care.
In this cross-sectional study, the participants will complete 4 times a set of
questionnaires and measurements. The data that will be collected is:
age; sex; height; weight; type of tumour; classification of malignant tumours (TNM);
progression of tumour and used therapy; blood sample to analyse albumin, creatine,
hemoglobin, LDH and CRP; use of parental nutrition; dietary assessment; use of nutritional
supplements; Quality of Life by using the EORTC-QlQ; Subjective Global Assessment; presence
of Percutaneous endoscopic gastrostomy; use of enteral or parenteral nutrition; body
composition based on a Bio Impedance Assessment; hand grip strength and mid upper arm
circumference. Based on all these data points a easy to use tool/score for a hospital
setting will be created. During the first assessment the measurements will be done in the
morning and the evening to test the reproducibility.
;
Time Perspective: Cross-Sectional
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT05603585 -
Optimal Protein Supplementation and Early Exercise In Mechanically Ventilated Patients
|
N/A | |
| Recruiting |
NCT06206785 -
Resting Energy Expenditure in Palliative Cancer Patients
|
||
| Enrolling by invitation |
NCT05028192 -
Mitochondria Preservation by Exercise Training: a Targeted Therapy for Cancer and Chemotherapy-induced Cachexia
|
||
| Completed |
NCT01696604 -
A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of GSK2849466 in Healthy Male Subjects
|
Phase 1 | |
| Recruiting |
NCT04627376 -
Multimodal Program for Cancer Related Cachexia Prevention
|
N/A | |
| Completed |
NCT02567773 -
Safety, Tolerability, Pharmacokinetic (PK), and Pharmacodynamic Study of GSK2881078 and Study to Evaluate the Effect of CYP3A4 Inhibition on PK of GSK2881078
|
Phase 1 | |
| Completed |
NCT00866970 -
Safety, Efficacy and Pharmacokinetics of ALD518 in Patients With Non-Small Cell Lung Cancer-related Fatigue and Cachexia
|
Phase 2 | |
| Active, not recruiting |
NCT00710632 -
Screening to Predict Weight Loss in Patients With Cancer
|
N/A | |
| Completed |
NCT00031785 -
Megestrol in Treating Patients Who Are Undergoing Radiation Therapy for Lung Cancer
|
Phase 3 | |
| Withdrawn |
NCT02017925 -
Pulmonary Rehabilitation in Improving Lung Function in Patients With Locally Advanced Non-Small Cell Lung Cancer Undergoing Chemoradiation
|
N/A | |
| Recruiting |
NCT01829880 -
Impact of Body Composition on Bisoprolol and Ramipril Pharmacokinetics in Patients With Chronic Heart Failure
|
N/A | |
| Completed |
NCT01692990 -
Study on the Effect of Fish Oil and Appetite
|
Phase 0 | |
| Completed |
NCT01419145 -
A Feasibility Study of Multimodal Exercise/Nutrition/Anti-inflammatory Treatment for Cachexia - the Pre-MENAC Study
|
N/A | |
| Completed |
NCT00994669 -
Development of a Non-invasive Assessment of Skeletal Muscle Loss in Cancer Patients
|
N/A | |
| Terminated |
NCT00851448 -
Safety, Tolerance and Efficacy of an Oral Nutritional Supplement in Lung Cancer Patients
|
N/A | |
| Terminated |
NCT00962234 -
Metabolism of Lipids in Advanced Cancer
|
N/A | |
| Completed |
NCT01015274 -
Non-invasive Assessment of Skeletal Muscle Loss in Cancer Patients
|
||
| Completed |
NCT00972634 -
Computerized Questionnaires in Assessing Symptoms, Pain, Depression, and Physical Function in Patients With Metastatic and/or Advanced Locoregional Cancer
|
N/A | |
| Terminated |
NCT00558558 -
Haelan and Nutrition in Cancer Patients
|
Phase 2 | |
| Terminated |
NCT00535015 -
Safety and Efficacy Study of Betamarc to Treat Loss of Weight and Appetite in Non-Small Cell Lung Cancer
|
Phase 2 |